The US FDA has for the very first time approved dermal filler for treating scars left by acne. It is estimated that there are 40 to 50 million people who suffer from acne.

The dermal filler is essentially made of bovine cartilage and has been christened as Bellafill. When injected it is designed in a way to raise and smoothen scars so that it is merges with the level of the adjoining skin. The procedure is only done in patients above 21.

Acne has been dubbed the bane of the teens. Though a number of treatments are available including gels and laser, the success ratio was low. Scars left behind by acne are deep and may or may not get filled.

Dr. Ava Shamban, an assistant clinical professor of dermatology at UCLA, who was involved in the Bellafill study, told Reuters, “Until now, multiple laser treatments or other injectables have been used but are limited both in terms of efficacy and longevity and are hampered by potential side effects.”